#401, 3071 Glen Drive
Coquitlam
Canada
Phone: (604) 941-7161
Fax: (604) 464-0103
Description:
Our drug delivery arm with the Skye Blue Organization (SBO) in pharmacogenic research including novel areas including bio-nutritionals, psycho-actives, cell and organ transplantation with cell proliferative systems and transgene pharmacogenesis.
Our company is a theoretical think-tank and industry body that proactively promotes the future of therapeutic modalities with biomedicine/biotech including the future possibilities with nutri-actives such as mind-body psycho-actives with folate-mediated metabolism, mood-altering functional, cognitive-enhancing and kinesiologic therapeutics with possible developmental applications, deconditioning and anti-addictive prevention therapeutics and gene-based transgenesis and treatment pre-partum and post-partum, organ and cell proliferative systems and medical diagnostics including monoclonals and future applications with functional foods for disease prevention.
One area we are investigating is the discovery of neurhormonal therapeutics to synthetic organochemicals that can approach the symptom of plaque in Alzheimers disease similar to drugs used to treat the diabetic condition of insulin insufficiency (i. e. as with type I and type II diabetes).
(An affiliate of the Skye Blue Organization (SBO) group of companies, Coquitlam, B. C. Canada.)